Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections

NCT06966427 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.

NCT NCT06966427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06966427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of a Dose Guidance System for People With Diabetes Initiating Basal Insulin or Using Insulin Injections
Lead sponsor
Rabin Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
May 8, 2025
Completion date
May 25, 2026
Enrollment
45 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes